Preparing for the Post-Brexit Clinical Supply Chain
Pharma Industry, Regulatory
For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now.
Related Education Resources.
All ResourcesCOVID-19 and the Clinical Supply Chain: Mitigating Risk and Maintaining Business Continuity
Topics: COVID-19, Pharma Industry, Supply Chain
Position Paper
Free
Medidata webinar - Evolution of Trial Virtualization & its Impact on Clinical Supplies
Topic: Supply Chain
Webinar
Free
Requirements of a QP
Topic: Pharma Industry
Video
Members